Fox Foundation offers $2m for ‘game-changing’ Parkinson’s breakthrough

PD in Practice

Author: Parkinson's Life editorsPublished: 7 July 2016

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

MJFF $2 grant

The Michael J Fox Foundation is offering US$2 million to the first researcher to develop a tracer for alpha-synuclein – the protein that is a strong pathological indicator of Parkinson’s disease.

Imaging of alpha-synuclein could become a useful biomarker of the presence of the disease and possibly even a measure of disease progression.

In a statement issued on its website, the Foundation said: “The ability to image alpha-synuclein deposition in the brain would be a game-changing achievement for the Parkinson’s disease field.

“With this prize, the Foundation seeks to attract research teams and accelerate momentum to speed the development of such a tracer.”

The prize is open to all academic and industry researchers and contestants may already be funded by the MJFF or not. There is no deadline and the $2 million prize will be awarded to the first contestant who submits “compelling evidence of a viable selective tracer and agrees to its widespread use”.


To see the full submission requirements, the judging panel and how to apply, visit the website here

Learn more about alpha-synuclein in this free podcast: ‘Stopping disease progression’

Go Back

Share this story

Comments


Related articles


sponsored article

Advances

KinetiGraph: tracking your symptoms on the move

A look at Parkinson’s KinetiGraph, a new objective measurement device

READ MORE
Parkinson's hospitals

Special reports

Are UK hospitals safe for people with Parkinson’s?

Two thirds of Parkinson’s patients do not get their medication on time

READ MORE

Europe

Parkinson’s 100 Challenge: the story so far…

A World Parkinson’s Day round-up from the challengers

READ MORE